Obesity — Examining Reach and Implementation of an Evidence-based Weight Loss Program in Rural Primary Care
Citation(s)
Akers JD, Estabrooks PA, Davy BM Translational research: bridging the gap between long-term weight loss maintenance research and practice. J Am Diet Assoc. 2010 Oct;110(10):1511-22, 1522.e1-3. doi: 10.1016/j.jada.2010.07.005.
Ard JD Unique perspectives on the obesogenic environment. J Gen Intern Med. 2007 Jul;22(7):1058-60. doi: 10.1007/s11606-007-0243-z. No abstract available.
Befort CA, Nazir N, Perri MG Prevalence of obesity among adults from rural and urban areas of the United States: findings from NHANES (2005-2008). J Rural Health. 2012 Fall;28(4):392-7. doi: 10.1111/j.1748-0361.2012.00411.x. Epub 2012 May 31.
Cancer Prevention and Control Research Network Putting Public Health Evidence in Action. Produced by the Centers for Disease Control and Prevention and the National Cancer Institute. Retreived from http://cpcrn.org/pub/evidence-in-action/, October 2017.
Chan L, Hart LG, Goodman DC Geographic access to health care for rural Medicare beneficiaries. J Rural Health. 2006 Spring;22(2):140-6. doi: 10.1111/j.1748-0361.2006.00022.x.
Chorpita BF, Daleiden EL, Weisz JR Identifying and selecting the common elements of evidence based interventions: a distillation and matching model. Ment Health Serv Res. 2005 Mar;7(1):5-20. doi: 10.1007/s11020-005-1962-6.
Ely AC, Befort C, Banitt A, Gibson C, Sullivan D A qualitative assessment of weight control among rural Kansas women. J Nutr Educ Behav. 2009 May-Jun;41(3):207-11. doi: 10.1016/j.jneb.2008.04.355.
Estabrooks PA, Glasgow RE Translating effective clinic-based physical activity interventions into practice. Am J Prev Med. 2006 Oct;31(4 Suppl):S45-56. doi: 10.1016/j.amepre.2006.06.019.
Glasgow RE, Goldstein MG, Ockene JK, Pronk NP Translating what we have learned into practice. Principles and hypotheses for interventions addressing multiple behaviors in primary care. Am J Prev Med. 2004 Aug;27(2 Suppl):88-101. doi: 10.1016/j.amepre.2004.04.019.
Green LW, Glasgow RE, Atkins D, Stange K Making evidence from research more relevant, useful, and actionable in policy, program planning, and practice slips "twixt cup and lip". Am J Prev Med. 2009 Dec;37(6 Suppl 1):S187-91. doi: 10.1016/j.amepre.2009.08.017. No abstract available.
Huang TT-K, Grimm B, Hammond RA A systems-based typological framework for understanding the sustainability, scalability, and reach of childhood obesity interventions. Child Heal Care. 2011;40(3):253-266. doi:10.1080/02739615.2011.590399
Perri MG, McAdoo WG, Spevak PA, Newlin DB Effect of a multicomponent maintenance program on long-term weight loss. J Consult Clin Psychol. 1984 Jun;52(3):480-1. doi: 10.1037//0022-006x.52.3.480. No abstract available.
Perri MG, Sears SF Jr, Clark JE Strategies for improving maintenance of weight loss. Toward a continuous care model of obesity management. Diabetes Care. 1993 Jan;16(1):200-9. doi: 10.2337/diacare.16.1.200.
Swinburn B, Egger G The runaway weight gain train: too many accelerators, not enough brakes. BMJ. 2004 Sep 25;329(7468):736-9. doi: 10.1136/bmj.329.7468.736.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.